Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryotaro Hida

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
No Shinkei Geka. Neurological Surgery|December 2, 2024
[Sleep Disorders]Keisuke Suzuki, Ryotaro Hida, Noriaki Morito
Head & Face Medicine|March 20, 2026
Interictal thermal pain hypersensitivity and central sensitization in migraine patients: a case-control study using quantitative sensory testingKeisuke Suzuki, Shiho Suzuki, Yasuo Haruyama, et al.
The Journal of Headache and Pain|February 19, 2025
The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraineKeisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, et al.
Cephalalgia : an International Journal of Headache|June 1, 2026
Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodiesKeisuke Suzuki, Shiho Suzuki, Saro Kobayashi, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
No Shinkei Geka. Neurological Surgery|December 2, 2024
[Sleep Disorders]Keisuke Suzuki, Ryotaro Hida, Noriaki Morito
Head & Face Medicine|March 20, 2026
Interictal thermal pain hypersensitivity and central sensitization in migraine patients: a case-control study using quantitative sensory testingKeisuke Suzuki, Shiho Suzuki, Yasuo Haruyama, et al.
The Journal of Headache and Pain|February 19, 2025
The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraineKeisuke Suzuki, Shiho Suzuki, Hiroaki Fujita, et al.
Cephalalgia : an International Journal of Headache|June 1, 2026
Real-world achievement of higher standards for migraine prevention with CGRP monoclonal antibodiesKeisuke Suzuki, Shiho Suzuki, Saro Kobayashi, et al.
Pageof 1